Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CING Cingulate > Detailed Quotes

CING Cingulate

Watchlist
0.951
-0.049-4.90%
Close  01/27 16:00 ET
0.9510.0000.00%
Post Mkt Price 01/27 19:28 ET
High
1.030
Open
1.010
Turnover
11.53K
Low
0.951
Pre Close
1.000
Volume
11.49K
Market Cap
10.75M
P/E(TTM)
Loss
52wk High
2.200
Shares
11.31M
P/E(Static)
Loss
52wk Low
0.664
Float Cap
8.16M
Bid/Ask %
-98.02%
Historical High
5.150
Shs Float
8.58M
Volume Ratio
0.43
Historical Low
0.664
Dividend TTM
--
Div Yield TTM
--
P/B
1.28
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.13%
Amplitude
7.95%
Avg Price
1.003
Lot Size
1
Float Cap
8.16M
Bid/Ask %
-98.02%
Historical High
5.150
Shs Float
8.58M
Volume Ratio
0.43
Historical Low
0.664
Dividend TTM
--
P/B
1.28
Dividend LFY
--
Turnover Ratio
0.13%
Amplitude
7.95%
Avg Price
1.003
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in 2013 and is headquartered in Kansas City, KS.
CEO: Dr. Shane J. Schaffer, Pharm.D.
Market: NASDAQ
Listing Date: 12/08/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist